Ernberg M, Lundeberg T, Kopp S
Department of Clinical Oral Physiology, Karolinska Institutet, Stockholm, Sweden.
Pain. 2000 Feb;84(2-3):339-46. doi: 10.1016/s0304-3959(99)00221-3.
We have previously reported that intramuscular injection of serotonin (5-HT) into the masseter muscle elicits pain and allodynia/hyperalgesia in healthy subjects. The aim of this study was to investigate whether the 5-HT(3) receptor antagonist granisetron or 5-HT(1A) receptor antagonist propranolol can reduce 5-HT induced pain and allodynia/hyperalgesia in the masseter muscle. Twenty-four healthy individuals (12 males and 12 females) without pain from the masseter muscle region participated. They were examined clinically including tenderness to digital palpation (TDP) and pressure pain threshold (PPT) of the masseter muscle. 5-HT in combination with granisetron or propranolol was randomly injected on one side in a double-blind manner. 5-HT in combination with saline was used on the contralateral side. After the injections the pain intensity and PPT were recorded 10 times during 30min. After the last recording the TDP was assessed again. The injections were repeated with the other antagonist within 1 week. All three combinations of substances elicited pain after injection, which lasted for 5-8min. 5-HT induced significantly more pain than granisetron+5-HT and propranolol+5-HT. The TDP increased significantly after injection of all combinations of substances, but there was no significant difference between them. The PPT decreased significantly after injection of 5-HT and increased significantly after injection of granisetron+5-HT, while it did not change significantly after injection of propranolol+5-HT. The difference between 5-HT and granisetron+5-HT was significant. In conclusion, the results of this study indicate that injection of granisetron and propranolol into the human masseter muscle reduces pain induced by local administration of 5-HT, but that the effect of granisetron is stronger than that of propranolol. In addition, granisetron totally abolishes allodynia/hyperalgesia.
我们之前曾报道,向健康受试者的咬肌内注射血清素(5-羟色胺,5-HT)会引发疼痛以及异常性疼痛/痛觉过敏。本研究的目的是调查5-HT3受体拮抗剂格拉司琼或5-HT1A受体拮抗剂普萘洛尔是否能减轻5-HT诱导的咬肌疼痛和异常性疼痛/痛觉过敏。24名无咬肌区域疼痛的健康个体(12名男性和12名女性)参与了研究。对他们进行了临床检查,包括咬肌的指触压痛(TDP)和压力痛阈(PPT)。将5-HT与格拉司琼或普萘洛尔联合以双盲方式随机注射到一侧。另一侧注射5-HT与生理盐水的组合。注射后,在30分钟内记录10次疼痛强度和PPT。最后一次记录后,再次评估TDP。在1周内用另一种拮抗剂重复注射。所有三种物质组合注射后均引发疼痛,持续5 - 8分钟。5-HT诱导的疼痛明显多于格拉司琼 + 5-HT和普萘洛尔 + 5-HT。注射所有物质组合后TDP均显著增加,但它们之间无显著差异。注射5-HT后PPT显著降低,注射格拉司琼 + 5-HT后PPT显著升高,而注射普萘洛尔 + 5-HT后PPT无显著变化。5-HT与格拉司琼 + 5-HT之间的差异显著。总之,本研究结果表明,向人咬肌内注射格拉司琼和普萘洛尔可减轻局部注射5-HT诱导的疼痛,但格拉司琼的效果强于普萘洛尔。此外,格拉司琼完全消除了异常性疼痛/痛觉过敏。